Literature DB >> 638049

Updating the Goeckerman regimen for psoriasis.

J W Petrozzi, J O Barton, K K Kaidbey, A M Kligman.   

Abstract

Various components of the Goeckerman regimen were analysed. Although our findings are preliminary, they indicate several important observations: (1) Irradiation of tar treated patients with UVA compared to UVB showed the most efficacious wavelengths to be in the erythemic range (UVB). (2) A 1% concentration of crude coal tar was as effective as 5 and 25%.(3) Application of tar 2 h prior to irradiation was equivalent to overnight usage. (4) Little difference was noted between hydrophilic ointment and petrolatum as vehicles. (5) A tar gel was less beneficial than crude tar. The benefits of the Goeckerman therapy are derived from the intrinsic antipsoriatic effects of both tar and UVB. For some the combination is additive and necessary for clearing; for others either of the components may have great benefit alone. Our favourable results with UVB alone indicate that its effectiveness has been understated and poorly appreciated. Minimizing the time of tar application without loss of efficacy makes treatment adaptable to outpatient practice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638049     DOI: 10.1111/j.1365-2133.1978.tb06538.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists.

Authors: 
Journal:  BMJ       Date:  1991-10-05

Review 2.  Psoriasis and its treatment.

Authors:  R H Champion
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

3.  Ultraviolet phototherapy in psoriasis with hydrophilic ointment alone or with crude coal tar.

Authors:  J W Petrozzi; O de los Reyes
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 4.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.